We trust computation to change drug discovery. The current market structure in drug discovery is indicative of low innovation. There is a known way to develop drugs, but it is artisanal and highly inefficient: an expensive lottery. At Acellera we believe that this can change.
We are impact driven, we would like to be the worldwide leader in innovating drug discovery with a strong company culture for innovation and science. At the moment, we have no external investment and a very simple cap table. In 2024, we are looking to raise funding and/or establish strategic partnerships to accomplish our ambitious goals. Currently, we are working to complete milestones that will demonstrate our approach. If you think that you might be the right partner to help achieve our mission, let’s start a conversation.